E-LIB Suche - Ergebnisse für: Valke, Lars L.F.G.

1

Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A: ..:

Valke, Lars L. F. G. ; Cloesmeijer, Michael E. ; Mansouritorghabeh, Hassan...
European Journal of Drug Metabolism and Pharmacokinetics. 49 (2024) 2 - p. 191-205 , 2024

Link: https://doi.org/10.1007/..

2

The Nijmegen ultra-sensitive Bethesda Assay detects very lo..:

Valke, Lars L.F.G. ; Verhagen, Marieke J.A. ; Mulders, Bart T.P.M....
Thrombosis Research. 231 (2023) - p. 112-120 , 2023

Link: https://doi.org/10.1016/..

3

Fibrinolytic assays in bleeding of unknown cause: Improveme..:

Valke, Lars L.F.G. ; Meijer, Danielle ; Nieuwenhuizen, Laurens...
Research and Practice in Thrombosis and Haemostasis. 6 (2022) 2 - p. e12681 , 2022

Link: https://doi.org/10.1002/..

4

Thrombin generation for monitoring hemostatic therapy in he..:

Verhagen, Marieke J.A. ; Valke, Lars L.F.G. ; Schols, Saskia E.M.
Journal of Thrombosis and Haemostasis. 20 (2022) 4 - p. 794-805 , 2022

Link: https://doi.org/10.1111/..

5

Combining factor VIII levels and thrombin/plasmin generatio..:

Bukkems, Laura H. ; Valke, Lars L. F. G. ; Barteling, Wideke...
British Journal of Clinical Pharmacology. 88 (2022) 6 - p. 2757-2768 , 2022

Link: https://doi.org/10.1111/..

6

Thrombin generation assays to personalize treatment in blee..:

Valke, Lars L. F. G. ; Rijpma, Sanna ; Meijer, Danielle..
Frontiers in Cardiovascular Medicine. 9 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Effect of emicizumab on thrombin generation: A case report ..:

Valke, Lars L. F. G. ; Beckers, Erik A. M. ; Blijlevens, Nicole M. A...
Haemophilia. 26 (2020) 6 - p. , 2020

Link: https://doi.org/10.1111/..

8

Cutaneous leishmaniasis that hit a returning traveller twic:

Valke, Lars L F G ; van Thiel, Pieter P A M ; Hassing, Robert-Jan
Journal of Travel Medicine. 27 (2020) 7 - p. , 2020

Link: https://doi.org/10.1093/..

9

Pharmacodynamic monitoring of factor VIII replacement thera..:

Valke, Lars L.F.G. ; Bukkems, Laura H. ; Barteling, Wideke...
Journal of Thrombosis and Haemostasis. 18 (2020) 12 - p. 3222-3231 , 2020

Link: https://doi.org/10.1111/..

10

Soluble CD30 does not predict late acute rejection or safe ..:

Valke, Lars L.F.G. ; van Cranenbroek, Bram ; Hilbrands, Luuk B..
Transplant Immunology. 32 (2015) 1 - p. 18-22 , 2015

Link: https://doi.org/10.1016/..

11

Thrombin generation for monitoring hemostatic therapy in he..:

Verhagen, Marieke J. A ; Valke, Lars L. F. G ; Schols, Saskia E. M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305107/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Thrombin generation assays to personalize treatment in blee..:

Valke, Lars L. F. G ; Rijpma, Sanna ; Meijer, Danielle..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684194/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Combining factor VIII levels and thrombin/plasmin generatio..:

Bukkems, Laura H ; Valke, Lars L. F. G ; Barteling, Wideke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304184/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Fibrinolytic assays in bleeding of unknown cause: Improveme..:

Valke, Lars L. F. G ; Meijer, Danielle ; Nieuwenhuizen, Laurens...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922970/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Pharmacodynamic monitoring of factor VIII replacement thera..:

Valke, Lars L.F.G ; Bukkems, Laura H ; Barteling, Wideke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756259/. , 2020

Link: http://www.ncbi.nlm.nih...